Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2

Maha Ayyoub, Andrea Merlo, Charles S. Hesdorffer, Daniel Speiser, Donata Rimoldi, Jean Charles Cerottini, Gerd Ritter, Yao Tseng Chen, Lloyd J. Old, Stefan Stevanovic, Danila Valmori

Research output: Contribution to journalArticle

Abstract

Because of their specific expression in tumors of different histological types, the products of the SSX genes are important candidate targets for development of cancer vaccines. We have previously identified two immunodominant SSX-2-derived T cell epitopes recognized by HLA-A2-restricted CD8 + T cells (SSX-2 41-49) and HLA-DR11-restricted CD4 + T cells (SSX-2 45-59), respectively. In this study, we report the identification of an HLA-DR3-restricted epitope mapping to the 37-51 region of SSX-2, overlapping both previously identified epitopes. As about one fifth of individuals from several major ethnic groups express HLA-DR3, the identification of this epitope significantly increases the percent of patients that are expected to mount specific CD4 + T cell responses following vaccination with peptides in this region of SSX-2. Retrieval of multiple overlapping epitopes in a defined region of SSX-2 protein suggests the presence of a "hot spot" for T cell recognition that may prove sufficient for the induction of immune responses.

Original languageEnglish (US)
Pages (from-to)70-78
Number of pages9
JournalClinical Immunology
Volume114
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Epitopes
HLA-DR3 Antigen
T-Lymphocytes
Epitope Mapping
HLA-A2 Antigen
Cancer Vaccines
T-Lymphocyte Epitopes
Ethnic Groups
Vaccination
Peptides
Genes
Neoplasms
Proteins

Keywords

  • Cancer
  • CD4 T cells
  • Immunotherapy
  • SSX-2
  • Tumor antigen

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Ayyoub, M., Merlo, A., Hesdorffer, C. S., Speiser, D., Rimoldi, D., Cerottini, J. C., ... Valmori, D. (2005). Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2. Clinical Immunology, 114(1), 70-78. https://doi.org/10.1016/j.clim.2004.08.014

Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2. / Ayyoub, Maha; Merlo, Andrea; Hesdorffer, Charles S.; Speiser, Daniel; Rimoldi, Donata; Cerottini, Jean Charles; Ritter, Gerd; Chen, Yao Tseng; Old, Lloyd J.; Stevanovic, Stefan; Valmori, Danila.

In: Clinical Immunology, Vol. 114, No. 1, 01.2005, p. 70-78.

Research output: Contribution to journalArticle

Ayyoub, M, Merlo, A, Hesdorffer, CS, Speiser, D, Rimoldi, D, Cerottini, JC, Ritter, G, Chen, YT, Old, LJ, Stevanovic, S & Valmori, D 2005, 'Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2', Clinical Immunology, vol. 114, no. 1, pp. 70-78. https://doi.org/10.1016/j.clim.2004.08.014
Ayyoub M, Merlo A, Hesdorffer CS, Speiser D, Rimoldi D, Cerottini JC et al. Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2. Clinical Immunology. 2005 Jan;114(1):70-78. https://doi.org/10.1016/j.clim.2004.08.014
Ayyoub, Maha ; Merlo, Andrea ; Hesdorffer, Charles S. ; Speiser, Daniel ; Rimoldi, Donata ; Cerottini, Jean Charles ; Ritter, Gerd ; Chen, Yao Tseng ; Old, Lloyd J. ; Stevanovic, Stefan ; Valmori, Danila. / Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2. In: Clinical Immunology. 2005 ; Vol. 114, No. 1. pp. 70-78.
@article{51841dcacdad41dbb552daff9d6ef0b6,
title = "Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2",
abstract = "Because of their specific expression in tumors of different histological types, the products of the SSX genes are important candidate targets for development of cancer vaccines. We have previously identified two immunodominant SSX-2-derived T cell epitopes recognized by HLA-A2-restricted CD8 + T cells (SSX-2 41-49) and HLA-DR11-restricted CD4 + T cells (SSX-2 45-59), respectively. In this study, we report the identification of an HLA-DR3-restricted epitope mapping to the 37-51 region of SSX-2, overlapping both previously identified epitopes. As about one fifth of individuals from several major ethnic groups express HLA-DR3, the identification of this epitope significantly increases the percent of patients that are expected to mount specific CD4 + T cell responses following vaccination with peptides in this region of SSX-2. Retrieval of multiple overlapping epitopes in a defined region of SSX-2 protein suggests the presence of a {"}hot spot{"} for T cell recognition that may prove sufficient for the induction of immune responses.",
keywords = "Cancer, CD4 T cells, Immunotherapy, SSX-2, Tumor antigen",
author = "Maha Ayyoub and Andrea Merlo and Hesdorffer, {Charles S.} and Daniel Speiser and Donata Rimoldi and Cerottini, {Jean Charles} and Gerd Ritter and Chen, {Yao Tseng} and Old, {Lloyd J.} and Stefan Stevanovic and Danila Valmori",
year = "2005",
month = "1",
doi = "10.1016/j.clim.2004.08.014",
language = "English (US)",
volume = "114",
pages = "70--78",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2

AU - Ayyoub, Maha

AU - Merlo, Andrea

AU - Hesdorffer, Charles S.

AU - Speiser, Daniel

AU - Rimoldi, Donata

AU - Cerottini, Jean Charles

AU - Ritter, Gerd

AU - Chen, Yao Tseng

AU - Old, Lloyd J.

AU - Stevanovic, Stefan

AU - Valmori, Danila

PY - 2005/1

Y1 - 2005/1

N2 - Because of their specific expression in tumors of different histological types, the products of the SSX genes are important candidate targets for development of cancer vaccines. We have previously identified two immunodominant SSX-2-derived T cell epitopes recognized by HLA-A2-restricted CD8 + T cells (SSX-2 41-49) and HLA-DR11-restricted CD4 + T cells (SSX-2 45-59), respectively. In this study, we report the identification of an HLA-DR3-restricted epitope mapping to the 37-51 region of SSX-2, overlapping both previously identified epitopes. As about one fifth of individuals from several major ethnic groups express HLA-DR3, the identification of this epitope significantly increases the percent of patients that are expected to mount specific CD4 + T cell responses following vaccination with peptides in this region of SSX-2. Retrieval of multiple overlapping epitopes in a defined region of SSX-2 protein suggests the presence of a "hot spot" for T cell recognition that may prove sufficient for the induction of immune responses.

AB - Because of their specific expression in tumors of different histological types, the products of the SSX genes are important candidate targets for development of cancer vaccines. We have previously identified two immunodominant SSX-2-derived T cell epitopes recognized by HLA-A2-restricted CD8 + T cells (SSX-2 41-49) and HLA-DR11-restricted CD4 + T cells (SSX-2 45-59), respectively. In this study, we report the identification of an HLA-DR3-restricted epitope mapping to the 37-51 region of SSX-2, overlapping both previously identified epitopes. As about one fifth of individuals from several major ethnic groups express HLA-DR3, the identification of this epitope significantly increases the percent of patients that are expected to mount specific CD4 + T cell responses following vaccination with peptides in this region of SSX-2. Retrieval of multiple overlapping epitopes in a defined region of SSX-2 protein suggests the presence of a "hot spot" for T cell recognition that may prove sufficient for the induction of immune responses.

KW - Cancer

KW - CD4 T cells

KW - Immunotherapy

KW - SSX-2

KW - Tumor antigen

UR - http://www.scopus.com/inward/record.url?scp=10444238427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10444238427&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2004.08.014

DO - 10.1016/j.clim.2004.08.014

M3 - Article

VL - 114

SP - 70

EP - 78

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -